19.11.2014 • NewsDuPontaccidentOSHA

Leaky Valve Suspected in DuPont Fatal Accident

A leaky valve in the methyl mercaptan production tract of DuPont's La Porte may have been at least partly to blame for the accident that killed four workers and injured a fifth on Nov. 16.
US news media quote the plant manager as saying that some of the workers were responding to the leak when they were overcome by toxic fumes.
The federal Chemical Safety Board has sent a seven-member team to Texas to investigate the accident, which officials said which killed "an unusually high number of people for an incident that didn't involve a fire or explosion."

According to the Wall Street Journal (WSJ), the focus of the probe is likely to be how the accident occurred despite a thicket of federal regulations.
Other media reports confirmed that the Texas plant was last inspected by the Occupational Safety and Health Administration (OSHA) seven years ago, when DuPont was fined $1,700 each for two serious safety violations.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.